$25.87
1.41% yesterday
NYSE, Nov 12, 10:14 pm CET
ISIN
US7170811035
Symbol
PFE

Pfizer Stock price

$25.87
+1.14 4.61% 1M
+2.78 12.04% 6M
-0.66 2.49% YTD
-0.32 1.22% 1Y
-23.37 47.46% 3Y
-9.70 27.27% 5Y
-5.76 18.21% 10Y
+4.79 22.74% 20Y
NYSE, Closing price Wed, Nov 12 2025
+0.36 1.41%

New AI Insights on Pfizer Insights AI Insights on Pfizer

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$147.1b
Enterprise Value
$193.8b
Net debt
$46.7b
Cash
$15.0b
Shares outstanding
5.7b
Valuation (TTM | estimate)
P/E
15.0 | 8.4
P/S
2.3 | 2.3
EV/Sales
3.1 | 3.1
EV/FCF
18.7
P/B
1.6
Dividends
DPS
$1.69
Yield 1Y | 5Y
6.5% | 4.2%
Growth 1Y | 5Y
2.4% | 4.1%
Payout 1Y | 3Y
119.9% | 68.3%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$62.8b | $63.5b
EBITDA
$23.3b | $24.4b
EBIT
$18.3b | $21.9b
Net Income
$9.8b | $17.5b
Free Cash Flow
$10.4b
Growth (TTM | estimate)
Revenue
3.9% | -0.2%
EBITDA
-5.3% | 10.7%
EBIT
-5.8% | 30.8%
Net Income
131.1% | 117.6%
Free Cash Flow
26.1%
Margin (TTM | estimate)
Gross
75.0%
EBITDA
37.1% | 38.4%
EBIT
29.1%
Net
15.7% | 27.5%
Free Cash Flow
16.5%
Financial Health
Equity Ratio
41.3%
Return on Equity
9.1%
ROCE
10.6%
ROIC
12.0%
Debt/Equity
0.7
More
EPS
$1.7
FCF per Share
$1.8
Short interest
2.2%
Employees
81k
Rev per Employee
$790.0k
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

14x Buy
47%
15x Hold
50%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a Pfizer forecast:

Buy
47%
Hold
50%
Sell
3%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
62,786 62,786
4% 4%
100%
- Direct Costs 15,727 15,727
34% 34%
25%
47,059 47,059
3% 3%
75%
- Selling and Administrative Expenses 13,836 13,836
7% 7%
22%
- Research and Development Expense 10,132 10,132
3% 3%
16%
23,287 23,287
5% 5%
37%
- Depreciation and Amortization 5,004 5,004
4% 4%
8%
EBIT (Operating Income) EBIT 18,283 18,283
6% 6%
29%
Net Profit 9,828 9,828
131% 131%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Positive
The Motley Fool
about 9 hours ago
Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.
Positive
The Motley Fool
about 19 hours ago
These two tried-and-tested healthcare giants have compelling portfolios and pipelines. Pfizer is moving on from the pandemic era, and a stream of acquisitions has bolstered its pipeline.
Neutral
Business Wire
about 19 hours ago
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 a.m. GMT. To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Informati...
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today